Alzheimer's disease & dementia

What is childhood dementia? And how could new research help?

"Childhood" and "dementia" are two words we wish we didn't have to use together. But sadly, around 1,400 Australian children and young people live with currently untreatable childhood dementia.


Enzyme replacement therapy approved for late-onset Pompe disease

(HealthDay)—Nexviazyme (avalglucosidase alfa-ngpt) was approved for the treatment of the rare inherited disorder late-onset Pompe disease in patients 1 year of age and older, the U.S. Food and Drug Administration announced ...

Diseases, Conditions, Syndromes

A new treatment for rare muscular disease

Rare diseases are sometimes the most difficult to treat because of a lack of research and fewer participants to study.

page 1 from 5